Esteves Simão, Martins Mafalda, Barros Filinto, Barros Fernanda, Canas Manuela, Vitor Paula, Seabra Manuel, Castro Maria M, Bastardo Isabel
Department of Anesthesiology, Hospital de Santo António, Porto, Portugal.
Eur J Anaesthesiol. 2013 May;30(5):243-9. doi: 10.1097/EJA.0b013e32835dccd7.
Residual neuromuscular blockade still presents despite the use of intermediate duration muscle relaxants and is a risk factor for postoperative morbidity.
To determine the incidence of incomplete postoperative neuromuscular recovery from anaesthesia in a postanaesthesia care unit.
Multicentre observational study.
Public Portuguese hospitals.
Adult patients scheduled for elective surgery requiring general anaesthesia with neuromuscular blocking agents.
An independent anaesthesiologist measured neuromuscular transmission by the TOF-Watch SX acceleromyograph. Train-of-four ratios at least 0.9 and less than 0.9 were assessed as complete and incomplete neuromuscular recovery following general anaesthesia, respectively.
The study population consisted of 350 patients [134 men and 216 women, mean (SD) age 54.3 (15.9) years]. Ninety-one patients had a train-of-four ratio less than 0.9 on arrival in the postanaesthesia care unit, an incidence of residual neuromuscular blockade of 26% [95% confidence interval (CI) 21 to 31%]. The most frequent neuromuscular blockers were rocuronium (44.2%) and cisatracurium (32%). A neuromuscular block reversal agent was used in 66.6% of the patients (neostigmine in 97%). The incidence of residual neuromuscular blockade in patients receiving reversal agents was 30% (95% CI 25 to 37%). There were no statistically significant differences in the occurrence of residual blockade relating to the neuromuscular blocker used, although higher percentages were observed for cisatracurium (32.4%) and vecuronium (32%) compared with atracurium (23.6%) and rocuronium (20.8%). Incomplete neuromuscular recovery was significantly more frequent among patients who had received a reversal agent (30.5 vs. 17.1%, P = 0.01). Incomplete neuromuscular recovery was more frequent in patients given propofol than in those exposed to sevoflurane (26.2 vs. 14.3%).
The incidence of incomplete neuromuscular recovery of 26% confirms that it is relatively frequent in the postoperative period and calls attention to the dimension of this problem in Portugal.
尽管使用了中时效肌松药,但残余肌松阻滞仍然存在,并且是术后发病的一个危险因素。
确定麻醉后护理单元中术后神经肌肉恢复不全的发生率。
多中心观察性研究。
葡萄牙公立医院。
计划接受需要使用神经肌肉阻滞剂的全身麻醉的择期手术的成年患者。
一名独立麻醉医师使用TOF-Watch SX加速度肌动描记器测量神经肌肉传递。四个成串刺激比值至少为0.9和小于0.9分别被评估为全身麻醉后神经肌肉完全恢复和不完全恢复。
研究人群包括350例患者[134例男性和216例女性,平均(标准差)年龄54.3(15.9)岁]。91例患者在到达麻醉后护理单元时四个成串刺激比值小于0.9,残余肌松阻滞发生率为26%[95%置信区间(CI)21%至31%]。最常用的神经肌肉阻滞剂是罗库溴铵(44.2%)和顺阿曲库铵(32%)。66.6%的患者使用了神经肌肉阻滞逆转剂(97%使用新斯的明)。接受逆转剂的患者中残余肌松阻滞发生率为30%(95%CI 25%至37%)。尽管与阿曲库铵(23.6%)和罗库溴铵(20.8%)相比,顺阿曲库铵(32.4%)和维库溴铵(32%)的百分比更高,但与所使用的神经肌肉阻滞剂相关的残余阻滞发生率没有统计学上的显著差异。接受逆转剂的患者中神经肌肉恢复不全明显更常见(30.5%对17.1%,P = 0.01)。使用丙泊酚的患者比使用七氟醚的患者神经肌肉恢复不全更常见(26.2%对14.3%)。
26%的神经肌肉恢复不全发生率证实了其在术后时期相对常见,并引起人们对葡萄牙这一问题严重程度的关注。